Clinical use of parnaparin in major and minor orthopedic surgery: a review. - Test2 - elhamkhani - TriplyDB

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

http://www.wikidata.org/entity/Q37019860

about

A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).

P2860

Q47316913-C187E3F7-87E8-4C49-820F-A736BCBC3DED

P2860

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

http://www.wikidata.org/entity/Q37019860

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@en

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@nl

type

label

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@en

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@nl

prefLabel

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@en

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@nl

P1433

Q37019860-DBD9F002-3388-4109-BA8B-93E297A810C2

P1476

Q37019860-E167E519-F6A1-4E17-8102-7821527B023D

P2093

Q37019860-02F5E6F5-5445-46E4-81CF-ACD26ACFBF82

Q37019860-16961830-6CF5-4E26-BEEF-CBC9C12ADAA1

Q37019860-4C87702D-288C-45DC-9260-FD6EC81B775E

Q37019860-5B95E080-1086-4DD1-B38C-AF8EFB319282

P2860

Q37019860-00B53AFA-6769-4463-9C69-A6758BA97362

Q37019860-14D560D3-730F-403C-A991-A30E70096B32

Q37019860-20A387B6-AC73-4630-8895-D9BAEA10F015

Q37019860-20F9F8A3-CC96-4C65-89C2-81E2F7A4A97F

Q37019860-2202073F-43D6-4D95-B8F2-21F6C5EF841D

Q37019860-2471BCCF-B8F1-4F26-A0D2-0D010ED038CA

Q37019860-2B63B936-8F7A-40CA-B248-CAA31415881B

Q37019860-2D399F23-0EF1-45A0-9AC6-D7E253D03084

Q37019860-2F0D1F42-9AC7-4F00-948B-B33D518641E6

Q37019860-3A2332A6-9BE2-49A9-B28B-58306B561992

P304

Q37019860-4BDE000E-A6EF-4E4C-88D2-48756BF4CBC7

P31

Q37019860-475E8E76-B5A7-43EB-8576-5EC00BD3B800

Q37019860-B42AAAD3-B2F8-4A4A-A849-5FFEF6C7B185

P356

Q37019860-007B7FCD-9B48-437C-AF34-D75DA7652AA5

P407

Q37019860-B4FDA533-5E31-444E-9BAB-460F4CACEA98

P433

Q37019860-82B96628-42DC-4FC8-B117-DFC0B540FD38

P478

Q37019860-0F32A8EF-B7D6-4B29-ABA6-A2CCE9E08E2C

P577

Q37019860-CAE02C85-4AFA-414A-B1B6-7186379BF494

P698

Q37019860-1D0F49A5-2B65-4158-A553-07DFD153741A

P921

Q37019860-0AFC49A5-5EDF-4367-9E6F-09345B628816

Q37019860-D6791FB3-5837-4B3F-A657-487A450AC81E

Q37019860-F6A01F5C-0F94-4814-82B7-F1F539BCEE60

P932

Q37019860-858C9451-DCBA-40B7-8C40-4994F88F3AE3

P356

P1433

Vascular Health and Risk Management

P1476

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

@en

P2093

Elena Zangheri

http://www.w3.org/2001/XMLSchema#string

Lucia Guerra

http://www.w3.org/2001/XMLSchema#string

Milena Montebugnoli

http://www.w3.org/2001/XMLSchema#string

Stefano Bugamelli

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy

Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study

Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data.

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.

P304

983-990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S3253

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19183746

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

mechanism of action

venous thromboembolism

P932

2605328

http://www.w3.org/2001/XMLSchema#string